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Abstract
Objectives To assess the long-term effects of various exercise modes on psychological distress in men with prostate cancer
on androgen deprivation therapy (ADT).
Patients and methods 135 prostate cancer patients aged 43–90 years on ADT were randomized to twice weekly supervised
impact loading and resistance exercise (ImpRes), supervised aerobic and resistance exercise (AerRes), and usual care/
delayed supervised aerobic exercise (DelAer) for 12 months, and completed measures of psychological distress using the
Brief Symptom Inventory-18 (BSI-18). BSI-18 provides three subscales for anxiety, depression, and somatisation, as well as
the global severity index (GSI) where higher scores indicate higher distress.
Results Following the intervention, somatization was not different to baseline, however, there were significant interactions
(p < 0.01) for depression, anxiety, and the GSI. In ImpRes, depression was reduced at 12 months compared to baseline and
6 months (0.78 ± 1.39 vs. 1.88 ± 3.24 and 1.48 ± 2.65, p < 0.001), as was the GSI (3.67 ± 4.34 vs. 5.94 ± 7.46 and 4.64 ±
4.73, p < 0.001) with anxiety reduced compared to baseline (1.08 ± 1.54 vs. 1.98 ± 2.56). Depression and the GSI decreased
(p < 0.05) in AerRes at 6 months but increased by 12 months, while in DelAer the GSI was reduced at 12 months compared
to 6 months (3.78 ± 3.94 vs. 5.25 ± 4.22, p= 0.031). Men with the highest level of anxiety, depression, somatization, and the
GSI improved the most with exercise (ptrend < 0.001).
Conclusion Various supervised exercise modes (aerobic, resistance and impact loading) are effective in reducing psycho-
logical distress in men with prostate cancer on ADT. Those with the highest level of psychological distress improved the
most. Supervised exercise should be prescribed to improve psychological health in prostate cancer patients on ADT.
Introduction
Androgen deprivation therapy (ADT) is a common treat-
ment for men with prostate cancer (PCa) [1]. Whilst
effective for cancer control, ADT is associated with a
myriad of physiological adverse effects, including osteo-
porosis, reduced muscle mass and strength, and increased
adiposity [2–4]. Importantly, the psychological impact of
the disease and its treatment remains a considerable burden,
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with numerous reports documenting significant psycholo-
gical distress in men with PCa undergoing ADT [3–6].
Moreover, emerging evidence indicates that ADT may be
associated with greater psychological distress compared to
other PCa treatments. For example, ADT has been asso-
ciated with a threefold greater risk of depression compared
to radiation alone in men treated for recurrent PCa [6]. In
addition, longer ADT duration has been associated with an
increased risk of depression and inpatient and outpatient
psychiatric treatments in men with localized PCa [7]. The
impact of psychological distress in men with PCa, particu-
larly when not addressed, can result in compromised quality
of life [5, 8]. Importantly, men with PCa and with depres-
sive disorders are less likely to undergo definitive therapy
and are at increased risk of suicide [9–11]. Consequently,
the management of psychological distress in patients with
PCa should be an important clinical objective in efforts to
improve quality of life and clinical outcomes [12, 13].
We have previously observed that physically inactive
men with PCa experience higher global distress and anxiety
than those who were physically active [14]. In non-PCa
populations, exercise has been shown to have a significant
antidepressant effect in people with depression [15], and in
those with other chronic conditions [16]. Recently, exercise
interventions that included specifically resistance-based
exercise have been shown to reduce depressive symptoms
in adults [17]. Nevertheless, in our previous systematic
review on interventions to improve PCa survivorship, we
reported that there were insufficient data available to
determine the effects of exercise on depression or anxiety
outcomes [18]. Similarly, others have only reported initial
positive trends for the effect of exercise on anxiety and
depression in men with PCa with few studies available [19].
Therefore, despite increasing evidence in other clinical
populations, there is limited research examining the impact
of exercise and different modes of exercise on psycholo-
gical distress in men with PCa. In this report, we examined
the effects of various exercise modes on psychological
distress in men with PCa on ADT who undertook a year-
long randomized controlled trial. We hypothesized that a
year-long intervention of different exercise modes would
result in reduced psychological distress and improved
physical function in men with PCa on ADT.
Patients and methods
Two hundred and ninety-three patients with PCa were
screened for participation from 2009 to September 2012 in
Perth, Western Australia and Brisbane, Queensland and
their progress through the study has been previously
described [20]. In brief, 130 patients were excluded for
various reasons which included: declined to participate, too
far to travel, ineligible, and unable to obtain physician con-
sent resulting in 163 patients entering the study. The Brief
Symptom Inventory-18 (BSI-18) to assess psychological
distress was included after recruitment commenced and was
administered to 135 patients and this forms the basis for this
report. Inclusion criteria included: histologically documented
PCa, a minimum exposure to ADT of 2 months, without
prostate specific antigen (PSA) evidence of disease activity,
and anticipated to remain hypogonadal for the subsequent
12 months. Regarding without PSA evidence of disease
activity, this was operationalized in two ways by the study
clinicians (NS, DJ). For those who recently initiated ADT,
PSA needed to fall significantly and anticipated to remain
low for the next year, while for those with established dis-
ease, low PSA had to remain low and stable with no indi-
cation of relapse in the next year. Exclusion criteria included:
bone metastases, musculoskeletal, cardiovascular, or neuro-
logical disorders that could inhibit them from exercising as
determined by their physician, inability to walk 400 m or
undertake exercise, and resistance training performed in the
previous 3 months. All participants obtained medical clear-
ance from their physician. The study was approved by the
University Human Research Ethics Committee and all par-
ticipants provided written informed consent.
Study design
This was a three-armed RCT with the primary endpoints
being bone mineral density and cardiovascular capacity
which we have reported previously [21, 22], and secondary
endpoints including self-reported patient outcomes and
physical function. Of the secondary outcomes, we have
reported on fatigue [20]. As previously reported [20–22],
potential participants were identified by their treating urolo-
gist/oncologist and referred to the study coordinator. Fol-
lowing a familiarization session and baseline assessment, the
135 participants in this report were randomly allocated to
either: impact loading+ resistance training (ImpRes, n= 49),
aerobic+ resistance training (AerRes, n= 50), or to usual
care/delayed exercise (DelAer, n= 36) stratified according to
time on ADT (< or ≥ 6 months). During the initial 6-month
period 12 patients in ImpRes and 6 in AerRes discontinued
the intervention, and 9 in DelAer were lost to follow-up.
During the second 6-month period, three, ten, and three
patients from ImpRes, AerRes, and DelAer, respectively,
ceased participation. The main reasons for discontinuing
were no longer interested in participating, poor health, injury,
and moved away or no longer contactable.
Exercise program
The exercise program has been previously described in
detail [20, 21, 23]. In brief, ImpRes underwent 12 months
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of supervised exercise twice weekly in University-affiliated
exercise clinics. The impact-loading component to target
bone consisted of a series of bounding, skipping, drop
jumping, hopping, and leaping activities that were pro-
gressive in nature. Resistance training consisted of six
principal exercises as well as supplementary exercises that
targeted the major upper and lower body muscle groups
with 2–4 sets of each exercise performed at an intensity of
6–12 RM (maximal weight that can be lifted 6–12 times). In
addition, the ImpRes group undertook training at home
2 days/week that consisted of skipping, hopping, leaping,
and drop jumping. The AerRes group underwent supervised
exercise in the clinic twice weekly for the initial 6 months
consisting of 20–30 min of aerobic-based exercise such as
walking/jogging and cycling or rowing on stationary erg-
ometers at 60–85% of estimated maximal heart rate (HR),
and the same resistance exercise program undertaken by
ImpRes. In addition, participants were encouraged to
undertake home-based aerobic activity such as walking/
cycling with the goal to accumulate 150 min/week of
aerobic-based activity. During the second 6-month period,
patients were provided with a home-based maintenance
program which required 150 min/week of aerobic activity
and resistance exercise using body weight and elastic bands.
The DelAer group were provided with a printed booklet
with information about exercise for the initial 6 months,
followed by 6 months of twice weekly exercise on a cycle
ergometer at an intensity of ~70% HR max for up to 30–40
min and flexibility exercises in the clinic under supervision.
All supervised exercise sessions for ImpRes, AerRes, and
DelAer were undertaken with the guidance of an Accredited
Exercise Physiologist and included small groups of up to
ten participants. During the 12-month study period, all
participants were asked to maintain customary physical
activity and dietary patterns.
Psychological distress
Psychological distress was assessed using the BSI-18 which
comprises three subscales of anxiety, depression, and
somatization, as well as a global severity index (GSI) which
is the sum of the three subscales. A 5-point Likert scale is
utilized for each of the 18 items from 0 indicating not at all
to 4 indicating always with the timespan relating to the past
7 days. Each subscale ranges from 0 to 24 with the GSI
ranging from 0 to 72. For clinical case finding, raw scores
were converted to gender-specific T-scores (with a mean of
50 and a standard deviation of 10) with the following case-
rules applied: (1) Standard case-rule, a GSI ≥ 63 or at least
two of the sub-scales with a T-score ≥ 63 [24]; (2) Zabora
case-rule, a GSI T-score ≥ 57 [25]; and (3) Recklitis case-
rule, if the GSI ≥ 50 [26]. The BSI-18 is a reliable
instrument for the assessment of psychological distress [27]
where higher scores on the subscales and the GSI indicate
higher distress [28].
Other measures
Height and weight were assessed using a stadiometer and
electronic scales, respectively, with body fat percentage
determined by dual-energy X-ray absorptiometry (DXA,
Hologic Discovery A, Waltham, MA, USA). Muscle
strength was determined for the chest press, leg press,
seated row, and leg extension using the one-repetition
maximum (1-RM) and reported as average strength, the
400-m walk was used as a measure of aerobic capacity, the
6-m backwards walk as a measure of dynamic balance, and
the repeated chair rise to standing (five times) for lower
body muscle function [29]. Testosterone and PSA were
measured commercially by an accredited Australian
National Association of Testing Authorities laboratory
(Pathwest Diagnostics, Perth, Western Australia).
Statistical analyses
Data were analyzed using IBM SPSS Version 24. Normality
of distribution was assessed using the
Kolmogorov–Smirnov test. Differences among groups at
baseline were assessed using one-way analysis of variance
(ANOVA) or the Kruskall–Wallis test, as appropriate, for
continuous data and chi-square for categorical data. Chan-
ges over the 12-month study period were assessed using a
two-way (group × time) repeated measures ANOVA.
Follow-up tests were performed if the interaction or main
effect for time was significant. Where appropriate the
Bonferroni post-hoc procedure for multiple comparisons
was used to locate the source of significant differences. Data
not normally distributed were log transformed (ln) for
analysis with ln (x+ 2) used for the BSI subscales and
global scale as scores included zero. To examine change in
psychological distress following supervised exercise
(ImpRes, baseline to 12 months; AerRes, baseline to
6 months; and DelAer, 6 months to 12 months), trend
analysis was performed using linear regression and entering
tertiles of anxiety, depression, somatization, and the GSI as
an ordinal variable. The Mann–Whitney U test was used to
examine magnitude of change following supervised exer-
cise between clinical cases and non-cases according to the
Zabora case rule and Recklitis case rule for anxiety,
depression, somatization, and the GSI. Intention-to-treat
was utilized for analyses using maximum likelihood
imputation of missing values (expectation maximization).
Tests were two-tailed with statistical significance set at an
alpha level of 0.05.
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Results
There were no differences among groups at baseline for any
demographic or clinical characteristic (Table 1). Men were
aged 43–90 years with a body fat 12.9–45.1%, were mostly
married, not currently employed, and non-smokers. The
exercise program had the desired effect resulting in a pro-
gressive improvement in muscle strength over the 12-month
period in ImpRes (p < 0.001) and in the first 6 months in
AerRes (p < 0.001) which was then maintained at
12 months (Table 2). Similarly, there were progressive
improvements in the 6-m backwards walk (p < 0.001) and
chair rise ability (p < 0.001) over 12 months in ImpRes with
the 400-m walk time (p= 0.005) improving by 12 months,
whereas in AerRes the improvement in 400-m walk (p <
0.001) and chair rise (p < 0.001) occurred by 6 months and
was then maintained during the 6-month home-based per-
iod. For DelAer, the improvements (p < 0.01) were mostly
observed after the second 6-month period following exer-
cise. As previously reported, there were no adverse events
directly related to the exercise programs undertaken [20].
Psychological distress
At baseline there were no differences among groups for the
three subscales anxiety, depression, and somatization, or the
GSI (p= 0.132–0.694). There was no change in somatiza-
tion over the study period, however, there were significant
interactions for depression (p < 0.001), anxiety (p= 0.002),
and GSI (p < 0.001) (Table 3). In ImpRes, depressive
symptoms and the GSI were reduced at 12 months com-
pared to baseline and 6 months, while anxiety was also
reduced at 12 months compared to baseline. For those in the
AerRes group, depressive symptoms and the GSI tended to
decline following supervised exercise but then increased
following the non-supervised home-based period such that
depressive symptoms at 12 months were greater than at
baseline and 6 months and the GSI was also higher at
12 months than 6 months. A similar pattern was also evi-
dent for anxiety which tended to be reduced following
supervised exercise but then increased following the non-
supervised period such that anxiety symptoms were greater
at 12 than 6 months in AerRes. For those in DelAer, there
was no significant change in any subscale while the GSI
was reduced at 12 months following exercise compared to
6 months. However, it should be noted that although scores
in the three subscales and the GSI did not significantly
change following the usual care period they were all higher
than at baseline.
When anxiety, depression, somatization, and the GSI
were examined by tertiles, there was a significant trend
(ptrend < 0.001) for those in the highest tertile of each sub-
scale and the GSI prior to the initiation of exercise (i.e.,
higher distress) to derive the most benefit following
supervised exercise, that is, have a reduction in psycholo-
gical distress (Fig. 1).
Table 1 Participant
characteristics.
ImpRes AerRes DelAer p value
(n= 49) (n= 50) (n= 36)
Age, yr (SD) 68.7 ± 9.3 69.1 ± 9.6 69.7 ± 8.4 0.869
Height, cm (SD) 173.5 ± 5.8 173.1 ± 6.7 171.9 ± 5.4 0.467
Weight, kg (SD) 84.5 ± 11.5 85.0 ± 16.0 87.6 ± 14.4 0.565
Body fat, % (SD) 27.7 ± 4.8 27.5 ± 6.1 29.1 ± 4.5 0.350
Employed, N (%) 22 (38.6) 17 (31.5) 19 (38.8) 0.571
Married, N (%) 44 (77.2) 42 (77.8) 43 (87.8) 0.720
Current smoker, N (%) 3 (5.3) 3 (5.6) 3 (6.1) 0.822
Gleason scorea 7.0 (7.0–8.3) 8.0 (7.0–9.0) 7.0 (7.0–8.3) 0.411
ADT time, monthsa 3.0 (2.0–4.5) 3.0 (2.0–4.3) 3.0 (2.0–4.0) 0.624
PSA, ng/mLa 0.4 (0.1–1.2) 0.2 (0.0–1.0) 0.4 (0.0–1.0) 0.599
Testosterone, pg/mLa 0.0 (0.0–1.3) 0.8 (0.0–1.1) 0.5 (0.0–0.9) 0.973
Other Conditions, N (%)
Cardiovascular disease 3 (6.1) 3 (6.0) 2 (5.6) 0.994
Hypertension 17 (34.7) 15 (30.0) 19 (52.8) 0.085
Dyslipidemia 9 (18.4) 13 (26.0) 9 (25.0) 0.626
Diabetes 3 (6.1) 7 (14.0) 7 (19.4) 0.175
ImpRes impact plus resistance exercise; AerRes aerobic plus resistance exercise; DelAer delayed followed by
aerobic exercise; SD standard deviation; PSA prostate specific antigen.
aMedian and interquartile range (IQR); missing vales: employed n = 5, married n = 5, smoker n = 3,
PSA n = 5, testosterone n = 6, Gleason score n = 14.
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Table 2 Physical performance
measures at baseline, 6 and
12 months.
Baseline (0) 6 months 12 months P value
Group × Time Time Comparisona
Average muscle strength (kg)
ImpRes 70.5 ± 21.2 81.6 ± 22.0 86.9 ± 22.0 <0.001 <0.001 0 < 6 < 12
AerRes 71.2 ± 22.2 82.6 ± 23.3 81.1 ± 22.8 0 < 6, 12
DelAer 70.8 ± 26.1 71.5 ± 23.7 77.4 ± 27.0 0, 6 < 12
400-m walk (s)b
ImpRes 274.6 ± 58.1 263.1 ± 49.1 259.4 ± 49.8 0.505 <0.001 0 > 12
AerRes 270.1 ± 52.6 255.1 ± 42.8 256.9 ± 49.2 0 > 6, 12
DelAer 277.1 ± 47.8 270.0 ± 45.5 267.9 ± 46.0 0 > 12
6-m backwards walk (s)b
ImpRes 19.3 ± 8.5 16.7 ± 6.4 15.8 ± 6.8 0.173 <0.001 0 > 6 > 12
AerRes 19.0 ± 7.2 17.1 ± 6.0 16.0 ± 6.1 0 > 6 > 12
DelAer 19.0 ± 7.3 18.6 ± 8.7 18.1 ± 9.7
Chair rise (s)b
ImpRes 13.3 ± 4.3 11.9 ± 3.9 10.9 ± 2.8 0.005 <0.001 0 > 6 > 12
AerRes 12.8 ± 2.8 11.8 ± 2.6 11.6 ± 2.2 0 > 6, 12
DelAer 14.4 ± 3.9 13.3 ± 2.8 11.6 ± 1.9 0 > 6 > 12
Values are the mean ± SD.
ImpRes impact plus resistance exercise; AerRes aerobic plus resistance exercise; DelAer delayed followed by
aerobic exercise.
aWithin-group multiple comparisons for baseline (0), 6, and 12 months, with a Bonferroni-corrected p < 0.05.
bStatistical analysis based on log transformed data.
Table 3 Psychological distress
based on BSI-18 at baseline, 6,
and 12 months.
Baseline (0) 6 months 12 months P value
Group × Time Time Comparisona
Anxiety
ImpRes 1.98 ± 2.56 1.27 ± 1.38 1.08 ± 1.54 0.002 0.098 0 > 12
AerRes 1.30 ± 1.97 0.91 ± 1.45 1.38 ± 1.77 6 < 12
DelAer 1.36 ± 2.46 1.41 ± 1.74 1.18 ± 1.80
Depression
ImpRes 1.88 ± 3.24 1.48 ± 2.65 0.78 ± 1.39 <0.001 0.623 0, 6 > 12
AerRes 1.46 ± 3.57 1.08 ± 1.76 1.70 ± 2.11 0, 6 < 12
DelAer 1.33 ± 1.71 1.45 ± 1.82 1.01 ± 1.24
Somatization
ImpRes 2.08 ± 2.92 1.89 ± 1.88 1.82 ± 2.00 0.148 0.241
AerRes 1.58 ± 2.02 1.30 ± 1.54 1.46 ± 1.76
DelAer 1.97 ± 2.38 2.34 ± 2.21 1.63 ± 1.89
Global Severity Index
ImpRes 5.94 ± 7.46 4.64 ± 4.73 3.67 ± 4.34 <0.001 0.074 0, 6 > 12
AerRes 4.34 ± 6.46 3.29 ± 4.19 4.49 ± 5.05 6 < 12
DelAer 4.67 ± 5.50 5.25 ± 4.22 3.78 ± 3.94 6 > 12
Values are the mean ± SD.
ImpRes impact plus resistance exercise, AerRes aerobic plus resistance exercise, DelAer delayed followed by
aerobic exercise.
aWithin-group multiple comparisons for baseline (0), 6, and 12 months, with a Bonferroni-corrected p <
0.05; Statistical analysis based on log transformed data.
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When T-scores were calculated, the mean scores at
baseline were within the normal range (anxiety mean of
46.0 and SD= 7.4, depression mean of 46.5 and SD= 7.6,
somatization mean of 49.2 and SD= 7.7, and GSI mean of
47.5 and SD= 8.2). The number of cases of clinical distress
based on the Standard, Zabora and Recklitis case rules at
baseline, 6 and 12 months, for ImpRes, AerRes and DelAer
are shown in Table 4. With the different criteria the number
of cases varied with most cases identified using the Reck-
litis case-rule which has the lowest GSI cut-off value. For
all three case rules, the number of cases were less at
6 months following exercise in ImpRes and AerRes with
further reduced cases in ImpRes at 12 months when the
Zabora and Recklitis case rules were applied. Conversely,
the number of cases were higher at 12 months in AerRes
following the non-supervised 6-month exercise period,
while the number of cases of distress were reduced in
DelAer following supervised training from 6 to 12 months.
Based on the Zabora and Recklitis case finding rules, those
classed as clinically distressed responded significantly bet-
ter to supervised exercise than non-cases (Supplementary
Table).
Fig. 1 Change in anxiety (A), depression (B), somatization (C), and
the global severity index (GSI, D) following supervised exercise
(ImpRes from baseline to 12 months, AerRes from baseline to
6 months, and DelAer from 6 months to 12 months). Tertile 1 (T1)
lowest symptoms to tertile 3 (T3) highest symptoms. P-value for trend
analysis.
Table 4 Case finding for clinical distress at baseline, 6 and 12 months.
Baseline 6 months 12 months
Case Non-case Case Non-case Case Non-case
Standard Case Rulea
ImpRes 2 47 1 48 1 48
AerRes 3 47 1 49 2 48
DelAer 1 35 0 36 0 36
Zabora Case Ruleb
ImpRes 7 42 4 45 3 46
AerRes 6 44 5 45 7 43
DelAer 4 32 5 31 2 34
Recklitis Case Rulec
ImpRes 23 26 20 29 17 32
AerRes 14 36 10 40 15 35
DelAer 15 21 16 20 13 23
ImpRes impact plus resistance exercise; AerRes aerobic plus resistance
exercise; DelAer delayed followed by aerobic exercise.
aStandard BSI-18 case rule, a global severity index (GSI) ≥ 63 or at
least 2 of the sub-scales with a T-score ≥ 63.
bZabora case rule, a GSI T-score ≥ 57.
cRecklitis case rule, a GSI ≥ 50.
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Discussion
To our knowledge, this is the first RCT to examine the long-
term effects of different exercise modalities on psycholo-
gical distress in men with PCa undergoing ADT. There
were three important findings: (1) various modes of super-
vised exercise were effective in reducing psychological
distress in men with PCa on ADT; (2) men with the highest
level of psychological distress improved the most as a result
of exercise; and (3) all exercise modes led to improvements
in objectively measured physical function.
Psychological distress is common in men with PCa across
treatment modalities and stages of disease. The prevalence
of depression and anxiety in men with PCa across treatment
trajectories has been estimated to be between 15 and 27%
[12]. In our sample, the prevalence of clinical distress at
baseline ranged between 4 and 38% as this variation was
dependent on the case rule employed (4.4% Standard; 12.6%
Zabora; and 38.5% Recklitis). Exercise has been proposed to
have a significant antidepressant effect in people with
depression [15]. However, previous systematic reviews
reported insufficient data available or only initial positive
trends for the effect of exercise on anxiety and depression in
this patient group [18, 19]. Here, we expand on these initial
findings by reporting the long-term effect of different exer-
cise modalities on psychological distress in men with PCa
undertaking ADT. The results indicate that various modes of
supervised exercise are effective at reducing elements of
psychological distress in men with PCa receiving ADT.
Interestingly, in two of the exercise groups (ImpRes and
AerRes), the exercise interventions included some form of
resistance-based exercise which has been shown to be an
important exercise mode to reduce depressive symptoms in
adults [17].
Importantly, the positive improvements in elements of
psychological distress in this study were largely a result of
the supervised portion of the exercise program in each
group. These results are consistent with those of a meta-
analysis demonstrating that the effects of exercise on
depressive symptoms were larger with programs supervised
or partially supervised [30]. Thus, elements of a supervised
exercise program such as social interaction with peers and
professionals, learning new skills and receiving positive
feedback may contribute to improvements in symptoms of
distress [30, 31]. From 6–12 months the AerRes patients
continued to perform resistance training, but at home with
elastic bands and the likely reduced intensity and volume of
resistance exercise may have also contributed to the initial
benefits of clinic-based exercise being diluted. We have
recently proposed strategies to improve the long-term effi-
cacy and adherence in non-clinic settings using digital
health technology such as the use of wearable sensors,
utilizing digital exercise platforms for prescription, delivery,
and instruction, and video chat with a qualified exercise
professional to monitor and support the patient [32].
We also observed that men with the highest level of
psychological distress improved the most as a result of
exercise. Distress screening for men with PCa has been well
validated [33] and contemporary models of psychological
care in cancer propose a stepped approach where the depth
of intervention is matched to the extent of distress [34]. As
we proposed for patients with higher fatigue [20], and in
this case for distress, screening patients on ADT for such
symptoms and directing tailored and supervised exercise
interventions to those with clinical symptoms should be part
of PCa treatment care strategies. Further, we would hypo-
thesize that interventions that integrate tailored exercise
programs with evidence-based psychological interventions
[13] may well provide the optimal platform for survivorship
care for this patient group [35].
As expected, the intervention also improved physical
function and these results are consistent with previous work
undertaken by our group and others [29, 36]. These changes
are clinically important as ADT is associated with reduced
muscle strength, functional performance, balance, and
musculoskeletal health increasing the risk of falls and
fractures in these patients [37]. Interestingly, all exercise
modes led to similar improvements in physical function
suggesting that patients on ADT can benefit from an array
of exercise programs when supervised and at appropriate
intensity and dosage.
Of interest, we recently reported in a comprehensive
meta-analysis and meta-regression that low volume
resistance-based exercise undertaken at a moderate-to-high
intensity led to improvements in fatigue and quality of life,
and also mitigated depression and anxiety symptoms in men
with prostate cancer [38]. The results from our current study
are in agreement with this but also suggest that low volume
aerobic exercise may be beneficial in improving psycholo-
gical distress.
Our study has several strengths and limitations worthy of
comment. This is the largest RCT to date examining the
effect of different supervised exercise modes including
resistance, impact loading and aerobic training on psycho-
logical distress in men with PCa on ADT. Psychological
distress was assessed using the BSI-18 which includes
subscales of anxiety, depression, somatization, and GSI and
is a reliable instrument for the assessment of psychological
distress. Nevertheless, there are some limitations that war-
rant attention. Although positive effects of exercise on
psychological distress were found, we did not specifically
target patients who were diagnosed or distressed using
specific cutoffs. Thus, an investigation of the impact of
different exercise modalities on symptoms in those
clinically distressed or depressed to gain further under-
standing of the interaction between exercise and personal
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characteristics is warranted. However, our results do indi-
cate that those with higher scores for anxiety, depression,
and somatization, as well as the GSI, and those classed as
clinically distressed based on the case-finding rules
employed in the study, responded better to exercise. In
addition, although patients in the AerRes group were
encouraged to accumulate further activity, the volume of
additional activity outside of the supervised sessions was
not recorded. Lastly, the men in this study were primarily in
their first year of ADT. Thus, these results may not be
generalizable to men on different treatment regimens or of a
more advanced disease stage.
In summary, various exercise modes when supervised
are effective in reducing psychological distress in men with
PCa on ADT. Moreover, those with the highest level of
psychological distress improved the most. Supervised
exercise can be prescribed to improve psychological health
in PCa patients on ADT. As a practical clinical recom-
mendation, the American College of Sports Medicine has
proposed a physician assessment and referral strategy to
exercise specialists that can be used as a model to facilitate
exercise supervision in the setting of oncology [39]. These
strategies are relevant to men with PCa and should be used
by their treating urologists/oncologists to improve exercise
participation and improve psychological distress.
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